Click to view full size

Se­nior In­ves­tiga­tive Jour­nal­ist

Amid grow­ing con­cerns over re­strict­ed com­pe­ti­tion in the phar­ma­ceu­ti­cal in­dus­try, the Fair Trade Com­mis­sion (FTC) has ad­vised the Pri­vate Phar­ma­cy As­so­ci­a­tion of Trinidad and To­ba­go that there may be suf­fi­cient grounds for mem­bers to sub­mit for­mal com­plaints re­gard­ing po­ten­tial breach­es of the Fair Trad­ing Act.

Mean­while, an of­fi­cial in­ves­ti­ga­tion by the Health Min­istry in­to con­cerns about ris­ing drug prices, sup­ply short­ages, and the con­cen­tra­tion of con­tracts among a lim­it­ed num­ber of sup­pli­ers with re­spect to the Chron­ic Dis­ease As­sis­tance Pro­gramme (CDAP) is yet to be­gin.